bioAffinity Technologies, Inc. Liquidation Value

BIAF Other

Cash & Equivalents

$6.45M
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $6.45M
Total Obligations: -$3.92M
$2.53M
Per share: $0.56
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $6.45M
AR: $26,295
Total Obligations: -$3.92M
$2.56M
Per share: $0.57
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $6.45M
AR: $26,295
Inventory: $53,548
Total Obligations: -$3.92M
$2.61M
Per share: $0.58
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$2.53M$0.56
Liquid Liquidation Value$2.56M$0.57
Operating Liquidation Value$2.61M$0.58

Key Components (as of 2025-12-31)

Cash & Equivalents$6.45M
Accounts Receivable$26,295
Inventory$53,548
Current Liabilities$2.91M
Long-term DebtN/A
Op. Lease Liability$342,098
Finance Lease$672,249
Shares Outstanding4.5M

Explore all 167 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$6.45M$26,295$53,548$761,901$2.91MN/A$342,098$672,249
2025-09-30$7.67M$27,143$35,234$940,761$2.36MN/A$375,139$125,755

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-03-16 View
2025-09-30 10-Q 2025-11-14 View
2025-06-30 10-Q 2025-08-14 View
2025-03-31 10-Q 2025-05-15 View
2024-12-31 10-K/A 2025-04-29 View
2024-12-31 10-K 2025-03-31 View
2024-09-30 10-Q 2024-11-14 View
2024-06-30 10-Q 2024-08-14 View

Community Notes

Loading notes...

Questions

Loading questions...